Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial

1. Dutton, S.J.
2. Ferry, D.R.
3. Blazeby, J.M.
4. Abbas, H.
5. Dahle-Smith, A.
6. Mansoor, W.
7. Thompson, J.
8. Harrison, M.
9. Chatterjee, A.
10. Falk, S.
11. Garcia-Alonso, A.
12. Fyfe, D.W.
13. Hubner, R.A.
14. Gamble, T.
15. Peachey, L.
16. Davoudianfar, M.
17. Pearson, S.R.
18. Julier, P.
19. Jankowski, J.
20. Kerr, R.
21. Petty, R.D.